GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 23 filers reported holding GAIN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,211 | -26.7% | 3,723 | +0.1% | 0.00% | – |
| Q2 2023 | $16,657 | -6.9% | 3,718 | +0.1% | 0.00% | – |
| Q1 2023 | $17,897 | +54.0% | 3,713 | +0.0% | 0.00% | – |
| Q4 2022 | $11,619 | +29.1% | 3,712 | +36.9% | 0.00% | – |
| Q3 2022 | $9,000 | -10.0% | 2,711 | +1.3% | 0.00% | – |
| Q2 2022 | $10,000 | -9.1% | 2,675 | +0.1% | 0.00% | – |
| Q1 2022 | $11,000 | – | 2,673 | +11521.7% | 0.00% | – |
| Q4 2021 | $0 | – | 23 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 23 | -4.2% | 0.00% | – |
| Q2 2021 | $0 | – | 24 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 151,132 | $807,000 | 1.04% |
| CM Management, LLC | 90,000 | $489,000 | 0.37% |
| Greenlight Capital | 546,560 | $2,968,000 | 0.17% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 58,100 | $315,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 50,000 | $267,000 | 0.01% |
| Veritable, L.P. | 25,064 | $136,000 | 0.00% |
| Banque Cantonale Vaudoise | 3,000 | $16,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 20,056 | $107,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 15,754 | $84,000 | 0.00% |
| MORGAN STANLEY | 800 | $4,000 | 0.00% |